Allianz Technology Trust (LON:ATT - Get Free Report)'s stock price hit a new 52-week high on Wednesday . The stock traded as high as GBX 344.20 ($4.45) and last traded at GBX 387.50 ($5.01), with a volume of 1902746 shares trading hands. The stock had previously closed at GBX 379 ($4.90).
Allianz Technology Trust Stock Down 2.2 %
The company's fifty day moving average is GBX 428.79 and its two-hundred day moving average is GBX 394.71. The stock has a market cap of £1.45 billion, a price-to-earnings ratio of 2.88 and a beta of 0.52.
Insider Activity at Allianz Technology Trust
In related news, insider Lucy Costa purchased 7,180 shares of the company's stock in a transaction on Friday, January 31st. The shares were bought at an average cost of GBX 441 ($5.70) per share, for a total transaction of £31,663.80 ($40,925.16). 2.10% of the stock is owned by corporate insiders.
About Allianz Technology Trust
(
Get Free Report)
Allianz Technology Trust is managed by the highly experienced AllianzGI Global Technology team based in San Francisco. The team benefits from its close proximity to Silicon Valley where many of the world's key technology companies are headquartered.
The Trust is a UK listed closed-end fund which aims to achieve long-term capital growth by investing principally in technology companies globally.
Further Reading
Before you consider Allianz Technology Trust, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Allianz Technology Trust wasn't on the list.
While Allianz Technology Trust currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio?
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
